Contrasting SI-BONE (NASDAQ:SIBN) and Quipt Home Medical (NASDAQ:QIPT)

Quipt Home Medical (NASDAQ:QIPT) and SI-BONE (NASDAQ:SIBN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership.

Analyst Ratings

This is a summary of recent ratings for Quipt Home Medical and SI-BONE, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quipt Home Medical	1	0	3	2	3.00
SI-BONE	0	0	6	0	3.00

Quipt Home Medical currently has a consensus price target of $6.25, suggesting a potential upside of 164.83%. SI-BONE has a consensus price target of $23.00, suggesting a potential upside of 86.86%. Given Quipt Home Medical’s higher possible upside, equities analysts clearly believe Quipt Home Medical is more favorable than SI-BONE.

Volatility and Risk

Quipt Home Medical has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Comparatively, SI-BONE has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500.

Profitability

This table compares Quipt Home Medical and SI-BONE’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quipt Home Medical	-1.95%	-4.51%	-2.01%
SI-BONE	-23.82%	-22.51%	-16.53%

Valuation & Earnings

This table compares Quipt Home Medical and SI-BONE”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quipt Home Medical	$221.74 million	0.46	-$2.78 million	($0.11)	-21.45
SI-BONE	$138.89 million	3.72	-$43.34 million	($0.92)	-13.38

Quipt Home Medical has higher revenue and earnings than SI-BONE. Quipt Home Medical is trading at a lower price-to-earnings ratio than SI-BONE, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

42.9% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 98.1% of SI-BONE shares are owned by institutional investors. 4.2% of Quipt Home Medical shares are owned by company insiders. Comparatively, 3.9% of SI-BONE shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Quipt Home Medical beats SI-BONE on 9 of the 14 factors compared between the two stocks.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

About SI-BONE

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.